Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PureGen Osteoprogenitor Cell Allograft: A Radiographic Analysis of Rate and Quality of Fusion in Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF)

NCT01291134 is registered in ClinicalTrials.gov with Alphatec Spine, Inc. as lead sponsor.

NCT NCT01291134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PureGen Osteoprogenitor Cell Allograft: A Radiographic Analysis of Rate and Quality of Fusion in Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF)
Lead sponsor
Alphatec Spine, Inc.
Phase
Observational
Overall status
Terminated
Start date
February 28, 2011
Completion date
August 31, 2013
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cervical degenerative disc disease